A Phase IIa Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Escalation Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation.

Trial Profile

A Phase IIa Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Escalation Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2013

At a glance

  • Drugs Plecanatide (Primary)
  • Indications Constipation
  • Focus Adverse reactions
  • Most Recent Events

    • 09 May 2013 Detailed positive findings will be presented at the 2013 Digestive Disease Week (DDW) and will be published in 2013, according to a Synergy Pharmaceuticals Inc media release.
    • 05 Nov 2010 According to a Synergy Pharmaceuticals media release the trial status changed from recruiting to completed.
    • 07 Oct 2010 Results will be presented at the American College of Gastroenterology Annual Scientific meeting (Poster Number P762), according to a Synergy Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top